Beam Therapeutics Sues Over Stolen Gene-Editing IP — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Beam Therapeutics filed a lawsuit late last week accusing former scientist Zi Jun "Emma" Wang of accessing its electronic laboratory notebooks late at night and on weekends to steal intellectual property.
- Beam alleges Wang used the information to co-found YolTech Therapeutics, a gene-editing startup based in Shanghai.
- YolTech recently partnered with VC firms RA Capital and RTW to form a new startup called Serapha Bio.
- Both YolTech and Serapha Bio are named as defendants alongside Wang in the case.
- The lawsuit comes amid escalating tensions between American biotech companies and their Chinese counterparts, placing gene-editing IP at the center of the dispute.
Why it matters: By naming YolTech, Serapha Bio, and the accused scientist as co-defendants, Beam has escalated from an internal personnel matter to a cross-border IP lawsuit that directly implicates two VC-backed entities. The case lands as U.S.-China biotech competition intensifies, with proprietary gene-editing platforms now contested openly in court.
Ask SkimNews
